Confound
发表于 2025-3-23 10:08:09
The Rx to OTC switch — creating the climate for changeWordPerfect was the world’s favourite word processing program.
Distribution
发表于 2025-3-23 17:34:59
Successful switch strategiesAs we have turned the comer into the new millennium, we have found famous brands returning to their product roots — a timely reminder that a successful brand was, and is, simply a very relevant product idea, well executed.
fibula
发表于 2025-3-23 19:23:06
http://reply.papertrans.cn/20/1904/190397/190397_13.png
Peristalsis
发表于 2025-3-24 01:48:33
Branding and its potential within the pharmaceutical industryelopment of trade, buyers would use brands as a means of distinguishing between the cattle of one farmer and another, and brands quickly became associated with quality and reliability. Thus brands provided buyers with a guide to choice, a role that has remained unchanged to the present day.
Type-1-Diabetes
发表于 2025-3-24 05:55:03
The valuation of pharmaceutical brandsSuch businesses have in the past amply repaid their investors, reflected in increased profits, dividends and share prices. The industry has relied for these profits on the ability of drug companies to pass on rising drug costs to the consumer in higher prices. This ability to charge high prices arises from the economic peculiarity of the industry.
独裁政府
发表于 2025-3-24 08:15:00
Brand packaging designn functional rather than decorative, and limited to the communication of essential information. But with the increase in brands moving from Rx to OTC, the design of brand packaging will take on a new importance.
aquatic
发表于 2025-3-24 11:40:18
http://reply.papertrans.cn/20/1904/190397/190397_17.png
angina-pectoris
发表于 2025-3-24 15:50:02
http://reply.papertrans.cn/20/1904/190397/190397_18.png
scrutiny
发表于 2025-3-24 22:40:02
http://reply.papertrans.cn/20/1904/190397/190397_19.png
sparse
发表于 2025-3-25 01:16:07
https://doi.org/10.1007/978-3-662-54234-7Such businesses have in the past amply repaid their investors, reflected in increased profits, dividends and share prices. The industry has relied for these profits on the ability of drug companies to pass on rising drug costs to the consumer in higher prices. This ability to charge high prices aris